FAT2 | FAT atypical cadherin 2 | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33680/65962_A_6_1_rna_selected_60x60.jpg) | Group enriched |
KRT5 | Keratin 5 | Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/59479/133812_B_8_1_rna_selected_60x60.jpg) | Group enriched |
LY6D | Lymphocyte antigen 6 complex, locus D | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24755/58231_B_8_1_rna_selected_60x60.jpg) | Group enriched |
PTPRZ1 | Protein tyrosine phosphatase, receptor-type, Z polypeptide 1 | Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images/15103/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/15103/34334_B_8_5_rna_selected_60x60.jpg) | Group enriched |
RHBG | Rh family, B glycoprotein (gene/pseudogene) | Predicted membrane proteins Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48489/114605_B_9_2_rna_selected_60x60.jpg) | Group enriched |
SERPINB2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 2 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15480/35524_A_4_6_rna_selected_60x60.jpg) | Group enriched |
SFN | Stratifin | Cancer-related genes Plasma proteins
| | | ![](/images/6268/ihc_cell_selected_60x60.jpg) | ![](/images/6268/17244_A_2_3_rna_selected_60x60.jpg) | Group enriched |
SLC10A6 | Solute carrier family 10 (sodium/bile acid cotransporter), member 6 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/16662/ihc_cell_selected_60x60.jpg) | ![](/images/16662/37497_B_7_1_rna_selected_60x60.jpg) | Group enriched |
TMEM45A | Transmembrane protein 45A | Predicted membrane proteins
| | ![](/images/24082/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/24082/52641_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/5963/137904_B_8_5_rna_selected_60x60.jpg) | Group enriched |
KLK8 | Kallikrein-related peptidase 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35761/127940_B_7_7_rna_selected_60x60.jpg) | Group enriched |
S100A7 | S100 calcium binding protein A7 | Cancer-related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/1453/ihc_cell_selected_60x60.jpg) | ![](/images/33766/101280_B_9_4_rna_selected_60x60.jpg) | Group enriched |
SERPINB5 | Serpin peptidase inhibitor, clade B (ovalbumin), member 5 | Plasma proteins
| | | ![](/images/20136/ihc_cell_selected_60x60.jpg) | ![](/images/9570/23677_A_4_2_rna_selected_60x60.jpg) | Group enriched |
TNFRSF18 | Tumor necrosis factor receptor superfamily, member 18 | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8025/24767_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
ARSF | Arylsulfatase F | Predicted membrane proteins
| | ![](/images/549/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/549/1000_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
BCL2L10 | BCL2-like 10 (apoptosis facilitator) | Mitochondrial proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42222/91973_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CD1A | CD1a molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9/1443_A_1_5_rna_selected_60x60.jpg) | Tissue enhanced |
CDH3 | Cadherin 3, type 1, P-cadherin (placental) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images/1767/if_selected_60x60.jpg) | ![](/images/2487/ihc_cell_selected_60x60.jpg) | ![](/images/1767/8163_A_3_3_rna_selected_60x60.jpg) | Tissue enhanced |
CLCA2 | Chloride channel accessory 2 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47192/107655_A_5_8_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN1 | Claudin 1 | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48319/122919_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
CXorf28 | Chromosome X open reading frame 28 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58883/131930_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
DLK2 | Delta-like 2 homolog (Drosophila) | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/61223/140699_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ENDOU | Endonuclease, polyU-specific | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12388/28768_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
EPHB3 | EPH receptor B3 | Cancer-related genes Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8184/22583_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
EPS8L1 | EPS8-like 1 | Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/41851/88506_B_5_8_rna_selected_60x60.jpg) | Tissue enhanced |
FAM83B | Family with sequence similarity 83, member B | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31464/66134_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
FAM83G | Family with sequence similarity 83, member G | | | ![](/images/23369/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/23940/151837_B_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/16217/140543_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
GRHL1 | Grainyhead-like 1 (Drosophila) | Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/6420/20392_A_4_2_rna_selected_60x60.jpg) | Tissue enhanced |
HES2 | Hes family bHLH transcription factor 2 | Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39462/82908_B_4_4_rna_selected_60x60.jpg) | Tissue enhanced |
IVL | Involucrin | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2243/6007_A_6_3_rna_selected_60x60.jpg) | Tissue enhanced |
JAG2 | Jagged 2 | Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/25481/59678_B_2_8_rna_selected_60x60.jpg) | Tissue enhanced |
KLK7 | Kallikrein-related peptidase 7 | Cancer-related genes Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26342/59469_B_9_6_rna_selected_60x60.jpg) | Tissue enhanced |
LRP4 | Low density lipoprotein receptor-related protein 4 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images/11934/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/11934/30001_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
MEGF6 | Multiple EGF-like-domains 6 | Predicted secreted proteins
| | ![](/images/52129/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/52129/120413_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
OTX1 | Orthodenticle homeobox 1 | Transcription factors
| | ![](/images/12341/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/52122/122680_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
POSTN | Periostin, osteoblast specific factor | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12306/29396_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
PPFIA3 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 | | | ![](/images/43567/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/43567/95515_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |
PPP1R13L | Protein phosphatase 1, regulatory subunit 13 like | Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/5016/16024_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
PRODH | Proline dehydrogenase (oxidase) 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20361/105357_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
PROM2 | Prominin 2 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46005/111143_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
PTGS1 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20315/45241_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
RNASE7 | Ribonuclease, RNase A family, 7 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/68225/152323_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
SCEL | Sciellin | Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/40154/89094_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |
SPTBN2 | Spectrin, beta, non-erythrocytic 2 | Disease related genes Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/9844/32665_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Transcription factors
| | | | ![](/images/326/770_B_5_1_rna_selected_60x60.jpg) | Tissue enhanced |
TFAP2C | Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | Transcription factors
| | | | ![](/images/16079/35103_B_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
TP63 | Tumor protein p63 | Disease related genes Plasma proteins Transcription factors
| | ![](/images/7010/if_selected_60x60.jpg) | ![](/images/83/ihc_cell_selected_60x60.jpg) | ![](/images/83/862_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
TP73 | Tumor protein p73 | Plasma proteins Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/2514/142947_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
USH1G | Usher syndrome 1G (autosomal recessive) | Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24360/54831_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |